0001363585-13-000012.txt : 20130610
0001363585-13-000012.hdr.sgml : 20130610
20130610162639
ACCESSION NUMBER: 0001363585-13-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130606
FILED AS OF DATE: 20130610
DATE AS OF CHANGE: 20130610
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brusegard David
CENTRAL INDEX KEY: 0001516920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 13903718
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
CITY: TORONTO
STATE: A6
ZIP: M5J 2G2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-06-06
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001516920
Brusegard David
555 RICHMOND STREET WEST, PO BOX 200
TORONTO
A6
M5V 3B1
ONTARIO, CANADA
0
1
0
0
Chief Operating Officer
Common Stock Purchase Option (Right to Buy)
0.001
2013-06-06
4
A
0
595239
0
A
2013-06-06
2018-06-06
Common Stock
595239
595239
D
On June 4, 2013, the Board of Directors of the issuer granted the reporting person options to purchase 595,239 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer effective June 6, 2013. The grant was made pursuant to the terms of the issuer's 2006 stock plan.
David Brusegard
2013-06-10